Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-11

Clinical Trial Update: Potential Role of Water-soluble Ubiquinol in Complementary Therapy for Pediatric Dilated Cardiomyopathy [NA]

View source ↗

Summary

A completed clinical trial investigated water-soluble ubiquinol as a complementary therapy for pediatric dilated cardiomyopathy. The registry entry notes the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Water-soluble ubiquinol (ubiquinol (Coenzyme Q10))

Snippet

Sponsor: Chung Shan Medical University | Conditions: Pediatric Dilated Cardiomyopathy | NA | Status: COMPLETED